Process for the synthesis of morphinane compounds and intermediates thereof

Details for Australian Patent Application No. 2004274038 (hide)

Owner GlaxosmithKline Australia Pty Ltd Johnson Matthey Public Limited Company

Inventors Smith, Craig; Halliday, Scott, Brian; Ritchie, Jarrod; Mitchell, Melville; Purcell, Stuart; Hayes, Nicholas; Wilson, Geroge, Scott; Waddell, Lucy

Agent Griffith Hack

Pub. Number AU-B-2004274038

PCT Pub. Number WO2005/028483

Priority 2003905153 22.09.03 AU

Filing date 22 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 10 March 2011

International Classifications

C07D 498/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 489/02 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

C07D 489/08 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/028483 Priority application(s): WO2005/028483

4 May 2006 Change of Name(s) of Applicant(s), Section 104

  Johnson Matthey Public Limited Company; GlaxoSmithKline Australia Pty Ltd The name of the applicant has been changed to Johnson Matthey Public Limited Company; GlaxosmithKline Australia Pty Ltd

10 March 2011 Application Accepted

  Published as AU-B-2004274038

7 July 2011 Standard Patent Sealed

4 August 2011 Corrigenda

  Applications Accepted - Name Index Under the names GlaxosmithKline Australia Pty Ltd and Johnson Matthey Public Limited Company, Application No. 2004274038, under INID (56) correct the Related Art to Krassnig, R. et al., "Optimization of the Synthesis of Oxycodone and 5Methyloxycodone", Archiv der Pharmazie, 1996, vol. 329 (6), pages 325-326 and WO 2002/016367

18 August 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 20 Jul 2011. Address for service in Australia - Griffith Hack Level 10 167 Eagle Street Brisbane QLD 4001

12 January 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 20 Jul 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274039-Wastewater purification method

2004274037-Composite steering rack